0.5 n m of [ 3 h]dadle (nonspecific binding defined with 10 μ m naltrexone) (CEREP Inc)
90
Structured Review
CEREP Inc
0.5 n m of [ 3 h]dadle (nonspecific binding defined with 10 μ m naltrexone)
0.5 N M Of [ 3 H]Dadle (Nonspecific Binding Defined With 10 μ M Naltrexone), supplied by CEREP Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%5B+3+h%5Ddadle/0+5+n+m+of+++3+h+dadle++nonspecific+binding+defined+with+10+%CE%BC+m+naltrexone+/pmc07455220-45-100-109
Average 90 stars, based on 1 article reviews
0.5 N M Of [ 3 H]Dadle (Nonspecific Binding Defined With 10 μ M Naltrexone), supplied by CEREP Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%5B+3+h%5Ddadle/0+5+n+m+of+++3+h+dadle++nonspecific+binding+defined+with+10+%CE%BC+m+naltrexone+/pmc07455220-45-100-109
Average 90 stars, based on 1 article reviews
0.5 n m of [ 3 h]dadle (nonspecific binding defined with 10 μ m naltrexone) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
In Vitro:Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: In vitro pharmacology Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Binding Assay:Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: In vitro pharmacology Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Inhibition:Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: In vitro pharmacology Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Labeling:Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: In vitro pharmacology Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Recombinant:Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: In vitro pharmacology Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 Article Title: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease Article Snippet: Binding affinity of the new chemical entities was calculated from the inhibition of the binding of a radioactively labeled ligand detected by scintillation method conducted on human recombinant μ opioid receptor-expressing HEK-293 cells exposed to 0.5 n m of [ 3 H]DAMGO (nonspecific binding defined with 10 μ m naloxone), on human recombinant κ opioid receptor-expressing Chinese hamster ovary (CHO) cells exposed to 1 n m of [ 3 H] {"type":"entrez-nucleotide","attrs":{"text":"U69593","term_id":"4205069","term_text":"U69593"}} U69593 (nonspecific binding defined with 10 μ m naloxone), and on human recombinant δ opioid receptor-expressing CHO cells exposed to 0.5 n m of [ 3 |